Register entry
- Registered sites
- 1
- Active NDC listings
- 5
- Live patents
- 2
- Exclusivities
- 1
- Countries
- 1
- Base
- United States
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Polarean, Inc. | 2500 Meridian Parkway, Suite 175, Durham, North Carolina (NC) 27713, United States (USA) | Finished drug manufacture | 3010132318078629330 |
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.
| Dosage form | NDCs |
|---|---|
| gas | 5 |
| Route | NDCs |
|---|---|
| respiratory (inhalation) | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| polarean, inc. | 5 |
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10583205 | XENOVIEWxenon xe-129 hyperpolarized | product | Feb 2035 |
| 11052161 | XENOVIEWxenon xe-129 hyperpolarized | product | Dec 2035 |
| Product | Exclusivity | Until |
|---|---|---|
| XENOVIEWXENON XE-129 HYPERPOLARIZED | NCE New chemical entity | Dec 2027 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| XENOVIEW | xenon Xe 129 hyperpolarized | gas, respiratory (inhalation) | 80534-0300NDA |
| XENOVIEW | xenon Xe 129 hyperpolarized | gas, respiratory (inhalation) | 80534-0500NDA |
| XENOVIEW | xenon Xe 129 hyperpolarized | gas, respiratory (inhalation) | 80534-0750NDA |
| XENOVIEW | xenon Xe 129 hyperpolarized | gas, respiratory (inhalation) | 80534-1000NDA |
| XENOVIEW | xenon Xe 129 hyperpolarized | gas, respiratory (inhalation) | 80534-6350NDA |
Neighbours
Registered in the same town
12- Almac Clinical Services, LLCDurham, NC · 3 sites
- Merck & Co., Inc.Durham, NC · 2 sites
- KBI Biopharma, Inc.Durham, NC · 2 sites
- PETNET Solutions, Inc.DURHAM, NC
- Novo Nordisk Inc.Durham, NC
- Eli Lilly and CompanyDurham, NC
- Encube Ethicals LimitedDurham, NC
- Oxford Biomedica (UK) LimitedDurham, NC
- United Therapeutics CorporationDurham, NC
- Aurolife Pharma LLCDurham, NC
- Avista Pharma Solutions, Inc. dba CambrexDurham, NC
- BioAgilytix Labs, LLCDurham, NC
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Polarean, Inc. FDA approved?
- Polarean, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Polarean, Inc.'s drugs manufactured?
- The FDA register lists Durham, NC. Registered operations: finished drug manufacture.
- What drugs does Polarean, Inc. make?
- 5 products are listed under Polarean, Inc. in the openFDA NDC Directory, most often as gas. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.